Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOCK: Diuretics in Early CKD
NCT05171686Phase 4Completed
- Sponsor
- VA Office of Research & Development
- Start
- Feb 2023
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of diuretic and medication suspension-Medtronic BRC in chronic kidney disease (CKD) and hypertension (HTN), sponsored by VA Office of Research & Development. Primary endpoint: N-terminal-pro-BNP at 4 weeks. Started Feb 2023; status: completed.
02
Drugs
diuretic and medication suspension-Medtronic BRC
03
Conditions
chronic kidney disease (CKD)hypertension (HTN)
Beyond the preview
Go deeper on NCT05171686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05171686.